These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34944548)

  • 1. A Computational Approach to Investigate TDP-43 RNA-Recognition Motif 2 C-Terminal Fragments Aggregation in Amyotrophic Lateral Sclerosis.
    Grassmann G; Miotto M; Di Rienzo L; Salaris F; Silvestri B; Zacco E; Rosa A; Tartaglia GG; Ruocco G; Milanetti E
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-binding protein 43 (TDP-43).
    Prakash A; Kumar V; Meena NK; Hassan MI; Lynn AM
    J Biomol Struct Dyn; 2019 Jan; 37(1):178-194. PubMed ID: 29279008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folding of the RNA recognition motif (RRM) domains of the amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 reveals an intermediate state.
    Mackness BC; Tran MT; McClain SP; Matthews CR; Zitzewitz JA
    J Biol Chem; 2014 Mar; 289(12):8264-76. PubMed ID: 24497641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
    Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
    J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
    Hergesheimer RC; Chami AA; de Assis DR; Vourc'h P; Andres CR; Corcia P; Lanznaster D; Blasco H
    Brain; 2019 May; 142(5):1176-1194. PubMed ID: 30938443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.
    Igaz LM; Kwong LK; Chen-Plotkin A; Winton MJ; Unger TL; Xu Y; Neumann M; Trojanowski JQ; Lee VM
    J Biol Chem; 2009 Mar; 284(13):8516-24. PubMed ID: 19164285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zn
    Preethi S; Bharathi V; Patel BK
    Int J Biol Macromol; 2021 Apr; 176():186-200. PubMed ID: 33577819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity.
    Wei Y; Lim L; Wang L; Song J
    Biochem Biophys Res Commun; 2017 Apr; 485(4):826-831. PubMed ID: 28257838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The molecular mechanisms of intracellular TDP-43 aggregates].
    Nonaka T; Arai T; Hasegawa M
    Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes.
    Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR
    Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into the multi-determinant aggregation of TDP-43 in motor neuron-like cells.
    Bozzo F; Salvatori I; Iacovelli F; Mirra A; Rossi S; Cozzolino M; Falconi M; Valle C; Carrì MT
    Neurobiol Dis; 2016 Oct; 94():63-72. PubMed ID: 27317832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43
    Xu Z; Zhang J; Tang J; Gong Y; Zou Y; Zhang Q
    Biophys Chem; 2024 Jul; 310():107230. PubMed ID: 38615537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Rearrangement upon Fragmentation of the Stability Core of the ALS-Linked Protein TDP-43.
    Morgan BR; Zitzewitz JA; Massi F
    Biophys J; 2017 Aug; 113(3):540-549. PubMed ID: 28793209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of TDP-43 RRM2 Partially Folded States and Their Significance to ALS Pathogenesis.
    Tavella D; Zitzewitz JA; Massi F
    Biophys J; 2018 Nov; 115(9):1673-1680. PubMed ID: 30309612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD.
    Yamashita T; Teramoto S; Kwak S
    Neurosci Res; 2016 Jun; 107():63-9. PubMed ID: 26723245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.
    Braak H; Ludolph A; Thal DR; Del Tredici K
    Acta Neuropathol; 2010 Jul; 120(1):67-74. PubMed ID: 20379728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the aggregation-prone regions from structural domains of human TDP-43.
    Kumar V; Wahiduzzaman ; Prakash A; Tomar AK; Srivastava A; Kundu B; Lynn AM; Imtaiyaz Hassan M
    Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):286-296. PubMed ID: 30315897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain.
    Conicella AE; Zerze GH; Mittal J; Fawzi NL
    Structure; 2016 Sep; 24(9):1537-49. PubMed ID: 27545621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
    Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.